Clinical Developments in Idiopathic Pulmonary Fibrosis: Expert Insights

Demographics of IPF in the USa-d

Major Goals of Treatment

Managing Shortness of Breath

Common Comorbidities in IPF

Additional Management Considerations

The State of IPF Management

Pirfenidone: The ASCEND Trial

Results

Results (cont)

Results (cont)

Adverse Events

Study Conclusions

Nintedanib: INPULSIS-1 and INPULSIS-2

Results

Time to First Acute Exacerbation

Adverse Events

Study Conclusion

Discussion of Potential Implications

IPF Clinical Research Network: PANTHER Trial

IPF Clinical Research Network: PANTHER Trial (cont)

Results

Conclusions

Abbreviations

References

References (cont)

References (cont)

References (cont)